d.mv m
Appearance
komponim kimik
instancë e
type of chemical entity
përdor
strukturë kimike
masa
346,116486 dalton[24]
formula kimike
C₁₇H₁₈N₂O₆[11]
kanonikja SMILES
CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC[11]
defined daily dose
World Health Organisation international non-proprietary name
nifedipine[10]
found in taxon
significant drug interaction
reagon fizikisht me
Calcium voltage-gated channel subunit alpha1 S[36]
Calcium voltage-gated channel subunit alpha1 C[36]
Calcium voltage-gated channel subunit alpha1 D[36]
Calcium voltage-gated channel subunit alpha1 F[36]
Glycine receptor alpha 1[36]
Glycine receptor alpha 3[36]
Glycine receptor beta[36]
Potassium voltage-gated channel, shaker-related subfamily, member 1[36]
Potassium voltage-gated channel subfamily A member 5[36]
Potassium voltage-gated channel, shaker-related subfamily, member 7[36]
Potassium voltage gated channel, Shaw-related subfamily, member 1[36]
nuclear receptor subfamily 1 group I member 2[36]
Transient receptor potential cation channel subfamily M member 3[36]
legal status (medicine)
boxed warning[37]
LiverTox likelihood score
LiverTox toxicity likelihood category B[38]
stylized name
NIFEdipine[42]
ka veçori: Tall Man lettering
lëshuar nga: Food and Drug Administration
referuar si: Nifedipine
MCN code
2933.39.43
kategoria në Commons
Nifedipine
Reference
- ^ a b c d e f Global Substance Registration System, 19 nëntor 2016, anglisht, nifedipine, I9ZF7L6G2L
- ^ a b ChEMBL, 19 nëntor 2016, anglisht, NIFEDIPINE, CHEMBL193
- ^ a b inferred from InChIKey
- ^ a b c d e f HYIMSNHJOBLJNT-UHFFFAOYSA-N, InChIKey
- ^ GF WordNet
- ^ ECHA Substance Infocard database, 27 dhjetor 2018, 100.040.529, Nifedipine, CAS no.: 21829-25-4
- ^ a b UniChem
- ^ Freebase Data Dumps, 28 tetor 2013
- ^ California Proposition 65 list of chemicals, 6 janar 2020, https://oehha.ca.gov/chemicals/nifedipine
- ^ a b c d ChEBI, 3 tetor 2016, anglisht, nifedipine, 7565
- ^ a b c d e PubChem, 19 nëntor 2016, anglisht, 4485, nifedipine
- ^ YSO-Wikidata mapping project, 7 shkurt 2022
- ^ OpenAlex, 26 janar 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
- ^ KBpedia, 9 korrik 2020
- ^ ChEBI release 2020-09-01
- ^ InChI=1S/C17H18N2O6/c1-9-13(16(20)24-3)15(14(10(2)18-9)17(21)25-4)11-7-5-6-8-12(11)19(22)23/h5-8,15,18H,1-4H3, International Chemical Identifier
- ^ Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard
- ^ Hazardous Substances Data Bank, 10 maj 2021, 28 tetor 2019, Nifedipine, 7775
- ^ DrugBank, anglisht, 17 nëntor 2015, DB01115, Nifedipine
- ^ ChemSpider, 19 nëntor 2016, anglisht, 4330, Nifedipine
- ^ IUPHAR/BPS Guide to PHARMACOLOGY, 19 nëntor 2016, anglisht, 2514, nifedipine
- ^ N0000146717, 27 shkurt 2018, NDF-RT
- ^ alkaloid
- ^ PubChem, 3 tetor 2016, anglisht, 4485, nifedipine
- ^ a b https://www.whocc.no/atc_ddd_index/?code=C08CA05
- ^ RxNorm, 203423, 14 shkurt 2018
- ^ RxNorm, 151131, 14 shkurt 2018
- ^ RxNorm, 542720, 14 shkurt 2018
- ^ RxNorm, 491311, 14 shkurt 2018
- ^ RxNorm, 541600, 14 shkurt 2018
- ^ A community-driven global reconstruction of human metabolism.
- ^ a b N0000146717, 13 dhjetor 2016, anglisht, NDF-RT
- ^ Drug Indications Extracted from FAERS, 2 tetor 2018
- ^ a b c d e A reference set of clinically relevant adverse drug-drug interactions, probably
- ^ a b c d e f g h i j k l m n o p q r s t u A reference set of clinically relevant adverse drug-drug interactions, established
- ^ a b c d e f g h i j k l m IUPHAR/BPS Guide to PHARMACOLOGY, 17 gusht 2016, 2514, anglisht
- ^ FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links., https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802
- ^ LiverTox, 8 prill 2021, https://www.ncbi.nlm.nih.gov/books/n/livertox/Nifedipine, 11 janar 2017
- ^ N0000146717, 5 mars 2018, NDF-RT
- ^ a b c Medical Subject Headings, 15 mars 2018, D009543
- ^ a b c California Proposition 65 list of chemicals, 18 mars 2020, https://oehha.ca.gov/chemicals/nifedipine
- ^ 2 shtator 2022, https://www.fda.gov/drugs/medication-errors-related-cder-regulated-drug-products/fda-name-differentiation-project